KCNH2 and cardiac arrhythmia: In the case of pentamidine, such precautions could have been therapeutically relevant since the sensitivity of standard assays of hERG interference (5.1–11.3 μM24,25) appears to underestimate the risk of arrhythmia at therapeutic mean plasma concentrations which are in the range of 0.1–0.5 μM26.